CHD Patient's Concern on Cardiac Rehabilitation

Coronary Heart Disease Clinical Trial

Official title:

CHD Patient' s Concern on Primary Cardiac Rehabilitation and Its Social Associated Factors

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05099692
• Other study ID #: N2021-10
• Status: Recruiting
• Start date: October 15, 2021
• Est. completion date: December 31, 2023

Study information

• Verified date: April 2022
• Source: Shenyang Northern Hospital
• Contact: Qiang Hu, Dr
• Phone: 15291494943
• Email: huqiang071[@]foxmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Our study focuses on the question about primary cardiac rehabilitation (CR) patients with coronary heart disease are concerned about demonstrating the association between the patients' view of CR and social associated factors. In our study, all participants are invited to choose at least 1 question in 15 questions or provide their questions regarding their doubt about the CR after filling in their personal information. The selectable questions can be categorized into five titles: the content or purpose of CR, the method of CR, the advantage of CR, the adverse effect of CR, and the expenditure of CR.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 3000
• Est. completion date: December 31, 2023
• Est. primary completion date: December 31, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age >18 years old
• patients diagnosed as coronary heart disease
• able to participate in cardiac rehabilitation after medical judgments for the first time
• understand the questionnaire content
• agree to participant in the study and provide the written informed consent

Exclusion Criteria:

• unable to complete the questionnaire
• patients who aren't willing or refuse to participate in the trial

Related Conditions & MeSH terms

• Cardiac Rehabilitation
• Coronary Artery Disease
• Coronary Disease
• Coronary Heart Disease
• Heart Diseases
• Myocardial Ischemia

Intervention

Behavioral:
• filling out the questionnaire
all participants in our study are invited to choose at least 1 question in 15 questions or provide their own questions regarding their doubt about the CR after filling in their personal information

Locations

Country	Name	City	State
China	Qiang Hu	Shenyang	Liaoning

Sponsors (1)

Lead Sponsor	Collaborator
Shenyang Northern Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The total number of different selected questions	All participants are invited to choose at least 1 question in 15 questions or provide their questions regarding their doubt about the CR after filling in their personal information. As a result, we calculate and collect the total number of different selected questions for each patients.	5 minutes
Primary	The variety of different selected questions	All participants are invited to choose at least 1 question in 15 questions or provide their questions regarding their doubt about the CR after filling in their personal information. As a result, we calculate and collect the variety of different selected questions for each patients.	5 minutes